| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |